News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
378 Results
Type
Article (21)
Press Release (357)
Section
Business (126)
Career Advice (1)
Deals (38)
Drug Development (8)
Employer Resources (2)
FDA (10)
Job Trends (9)
News (184)
Policy (15)
Tag
Africa (1)
Alliances (25)
Approvals (9)
Asia (4)
Australia (3)
Best Places to Work (9)
C2C Services and Suppliers (10)
California (1)
Career advice (1)
Clinical research (4)
COVID-19 (3)
Diagnostics (3)
Earnings (29)
Employer resources (1)
Europe (18)
Events (40)
FDA (10)
Government (3)
Healthcare (4)
Hotbed/Location (290)
Infectious disease (3)
IPO (13)
Job search strategy (1)
Legal (1)
Management (1)
Medical device (14)
Medtech (14)
Mergers & acquisitions (24)
Neuropsychiatric disorders (1)
Neuroscience (1)
New York (1)
NextGen Class of 2024 (4)
North Carolina (1)
Pennsylvania (1)
People (60)
Phase I (3)
Phase II (2)
Phase III (3)
Preclinical (3)
Psychedelics (1)
Real estate (4)
Recruiting (1)
Regulatory (13)
Research institute (1)
Startups (4)
United States (4)
Date
Last 30 days (1)
Last 365 days (19)
2024 (11)
2023 (27)
2022 (42)
2021 (73)
2020 (27)
2019 (38)
2018 (32)
2017 (26)
2016 (22)
2015 (29)
2014 (16)
2013 (17)
2012 (10)
2011 (1)
2010 (6)
378 Results for "certara".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Certara to Participate in the 2024 Jefferies Global Healthcare Conference
Certara, Inc., a global leader in biosimulation, announced that Company management will participate in the Jefferies Global Healthcare Conference.
May 29, 2024
·
1 min read
Business
Certara Reports First Quarter 2024 Financial Results
Certara, Inc., a global leader in biosimulation, reported its financial results for the first quarter of fiscal year 2024.
May 7, 2024
·
23 min read
Business
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2024 after the market close on Tuesday, May 7th, 2024.
April 9, 2024
·
1 min read
Deals
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
July 9, 2024
·
5 min read
Business
Certara Reports Fourth Quarter 2023 Financial ResultsProvides Full Year 2024 Financial Guidance
Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter of fiscal year 2023.
February 29, 2024
·
25 min read
Business
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
July 2, 2024
·
1 min read
Pharm Country
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
Certara, Inc., a global leader in biosimulation, announced the introduction of Simcyp™ Biopharmaceutics software.
November 21, 2023
·
2 min read
Business
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and full year of 2023 after the market close on Thursday, February 29th, 2024.
February 1, 2024
·
1 min read
Deals
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
Certara, Inc. announced it has acquired Applied BioMath, an industry-leader in providing model-informed drug discovery and development support to help accelerate and de-risk therapeutic research and development.
December 13, 2023
·
3 min read
Business
Certara Reports Third Quarter 2023 Financial ResultsReiterates Full Year 2023 Financial Guidance
Certara, Inc., a global leader in biosimulation, reported its financial results for the third quarter of fiscal year 2023.
November 8, 2023
·
25 min read
1 of 38
Next
